Retail earnings and the consumer, GLP-1 stocks : Market Domination

It's that time of the day again — the final hour of trading — which means it's time for Market Domination with Julie Hyman and Josh Lipton as they cover the day's biggest industry stories and market themes heading into the closing bell.

Deutsche Bank Securities senior US economist Brett Ryan comes onto the program to discuss what investors are expecting from the Federal Reserve's interest rate policies ahead of the September FOMC meeting and Chair Jerome Powell's speech at the Jackson Hole Economic Symposium on Friday, noting whether the payroll revisions released earlier today will influence any monetary policy decisions.

Storch Advisors CEO Jerry Storch — who is also the former CEO of both Toys R Us and Hudson's Bay — addresses what earnings from major retailers like Target (TGT) are signaling about the strength of the US consumer.

As part of the latest installment of Good Buy or Goodbye, RSE Ventures Co-Founder and CEO Matt Higgins argues why he is buying stock in Viking Therapeutics (VKTX) over the opportunity it presents in the GLP-1 weight-loss drug craze among pharmaceutical companies while avoiding DexCom (DXCM).

Other top trending tickers on the Yahoo Finance platform include Keysight Technologies (KEYS), American Express (AXP), Walmart (WMT), and JD.com (JD).

This post was written by Luke Carberry Mogan.

Advertisement